Intensity Therapeutics, Inc. (INTS) Q1 2025 Earnings
INTS·Reported May 13, 2025·Before market open
Diluted EPS came in at $-0.22 (+35.3% YoY), missed the $-0.21 consensus by $0.01.
Diluted EPS
$-0.22missed by $0.01
Consensus: $-0.21
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Intensity Therapeutics, Inc.'s Q1 2025 earnings report.
Intensity Therapeutics, Inc. (INTS) reported Q1 2025 earnings on May 13, 2025 before market open.
Intensity Therapeutics, Inc. reported diluted EPS of $-0.22 for Q1 2025.
EPS missed the consensus estimate of $-0.21 by $0.01.
Compared to the same quarter a year prior, diluted EPS grew 35.3% from $-0.34.
You can read the 10-Q periodic report (0001567264-25-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.